Cargando…
Next-generation sequencing in advanced Chinese melanoma reveals therapeutic targets and prognostic biomarkers for immunotherapy
Limited studies have interrogated the genomic landscape of Chinese melanoma in which acral and mucosal melanoma are the mainstay. In this study, we carried out a retrospective analysis on 81 Chinese melanoma patients (15 acral, 25 mucosal and 41 cutaneous melanoma). With the identification of 1114 m...
Autores principales: | Huang, Fuxue, Li, Jingjing, Wen, Xizhi, Zhu, Baoyan, Liu, Wei, Wang, Jiuhong, Jiang, Hang, Ding, Ya, Li, Dandan, Zhang, Xiaoshi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187737/ https://www.ncbi.nlm.nih.gov/pubmed/35688842 http://dx.doi.org/10.1038/s41598-022-13391-y |
Ejemplares similares
-
Time-varying pattern of recurrence risk for localized melanoma in China
por: Wen, Xizhi, et al.
Publicado: (2020) -
Nomogram for predicting prognosis of patients with metastatic melanoma after immunotherapy: A Chinese population–based analysis
por: Zhao, Jingjing, et al.
Publicado: (2022) -
Melanoma Immunotherapy: Next-Generation Biomarkers
por: Hogan, Sabrina A., et al.
Publicado: (2018) -
An immune risk score predicts progression-free survival of melanoma patients in South China receiving anti-PD-1 inhibitor therapy—a retrospective cohort study examining 66 circulating immune cell subsets
por: Chi, Peidong, et al.
Publicado: (2022) -
Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma
por: Nyakas, M., et al.
Publicado: (2019)